Dogwood Therapeutics, Inc. Class of Warrant or Right, Outstanding
Dogwood Therapeutics, Inc. (DWTX) had Class of Warrant or Right, Outstanding of 4.39 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-14
- 2026-06-30: Class of Warrant or Right, Outstanding 4.39M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 4.39M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 855.00 shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.75K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 4.39M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 4.39M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 855.00 shares 10-K · filed 2026-03-18 | |
| 2025-09-30 | 7.75K shares 10-Q · filed 2025-11-07 | |
| 2025-06-30 | 7.75K shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 7.75K shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 7.75K shares 10-K · filed 2026-03-18 | |
| 2024-09-30 | 7.75K shares 10-Q · filed 2024-11-08 | |
| 2024-06-30 | 193.88K shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 193.88K shares 10-Q · filed 2024-05-10 | |
| 2023-12-31 | 7.75K shares 10-K · filed 2026-03-18 | 193.88K shares 10-K · filed 2024-03-01 |
| 2023-09-30 | 193.88K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 204.88K shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 672.50K shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 26.90K shares 10-K · filed 2025-03-31 | 672.50K shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 672.50K shares 10-Q · filed 2022-11-14 | |
| 2021-12-31 | 172.50K shares 10-K/A · filed 2024-03-08 | 104.08K shares 10-K · filed 2022-03-18 |
| 2020-12-31 | 172.50K shares 10-K · filed 2023-03-14 | |
| 2020-12-16 | 105.04K shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |